Drug-induced hemangiomas are reported side-effects for some drugs in nonclinical toxicology animal models, studying carcinogenesis. This allows the DOCS to be viable in both clinical and nonclinical populations. The Muse cell preparation is currently being tested in nonclinical toxicity studies. The original CVLT was normed on a 'reference sample' of 273 nonclinical subjects. As of 2016, nonclinical data suggest potential concerns. In Vivo Pharmacology, Nonclinical Imaging, Nonclinical Pathology, PK/TK Analysis and Reporting, and Immunology Services.